Oral mucosal electroporation device and use thereof

Patent metadata

Field	Value
Publication number	US-10124159-B2
Application number	US-201113641977-A
Country	US
Kind code	B2
Filing date	Apr 28, 2011
Priority date	Apr 28, 2010
Publication date	Nov 13, 2018
Grant date	Nov 13, 2018

Abstract

The present invention relates to electroporation (EP) devices that are able to generate an electroporation causing electrical field at the mucosal layer, and preferably in a tolerable manner. Further, it includes the generation of a protective immune response, cellular and/or humoral, using the oral EP device along with a genetic construct that encodes an immunogenic sequence.

First claim

What is claimed is:

1. A device for electroporating cells of a mucosal membrane of a mammal, wherein the device comprises:
an electrode microneedle plate, wherein said electrode microneedle plate comprises a plurality of microneedles configured to contact the mucosal membrane and deliver at least one pulse of electrical energy having an electrical potential sufficient to electroporate said cells,
a voltage return electrode positioned across from the electrode microneedle plate, wherein the voltage return electrode and the electrode microneedle plate are configured to be on opposite sides of the mucosal membrane,
a main housing in physical communication with said electrode microneedle plate and voltage return electrode, wherein the main housing is in fluid communication with a syringe capable of storing a pharmaceutical formulation for delivery through the electrode microneedle plate;
a piston in physical communication between the main housing and the electrode microneedle plate, the piston located remote from the syringe and interposed between the syringe and the electrode microneedle plate, wherein the piston is actuatable so as to distribute the pharmaceutical formulation through the electrode microneedle plate, and
an energy source in electrical communication with said electrode microneedle plate and said voltage return electrode, wherein the energy source is capable of generating said electric potential and delivering said electric potential to said cells through said electrode microneedle plate and said voltage return electrode.

2. The device according to claim 1 , wherein the syringe is capable of storing the pharmaceutical formulation for delivery via the microneedles.

3. The device according to claim 2 , wherein the microneedles of said electrode microneedle plate are made from electrically conductive materials comprising gold and silver plated brass, gold and silver plated copper, stainless steel, or titanium.

4. The device according to any one of claims 2 or 3 ,
wherein said piston is actuatable so as to cause even distribution of said pharmaceutical formulation through said electrode microneedle plate.

5. The device according to any one of claims 2 or 3 , wherein said energy source is capable of delivering through said electrode microneedle plate to said cells of the mucosal membrane at least one pulse of electrical energy having characteristics of between 1V and 30V, 2 mA and 100 mA, or 1 mS and 250 mS.

6. The device according to any one of claims 2 or 3 , wherein said mucosal membrane comprises buccal, nasal, esophageal, rectal, vaginal, vulva, intestinal, bowel, stomach, bladder, urinary tract, or eye tissue.

7. The device of claim 1 , wherein the main housing includes an arm moveable with respect to the electrode microneedle plate, and wherein the electrode microneedle plate is coupled to the main housing and the voltage return electrode is coupled to the arm.

8. The device according to claim 1 , wherein the piston faces the electrode microneedle plate so as to define a manifold area therebetween, and the piston is configured to drive the pharmaceutical formulation through the electrode microneedle plate.

9. The device according to claim 8 , wherein the piston is configured to drive an even distribution of the pharmaceutical formulation through the electrode microneedle plate.

10. The device according to claim 9 , wherein the piston carries a sealing o-ring in contact with an interior of the main housing.

11. The device according to claim 1 , wherein the main housing is configured to be locked to the syringe.

12. The device according to claim 11 , wherein the main housing and the syringe collectively define a luer lock.

13. A method of administering a pharmaceutical formulation to cells of a mucosal membrane of a mammal with said device according to claim 1 , said method comprising:
contacting said electrode microneedle plate to said mucosal membrane,
delivering said pharmaceutical formation to said mucosal membrane, and
applying an electroporation-causing electrical pulse to said mucosal membrane through said electrode microneedle plate, wherein the electroporation-causing electrical pulse was generated by said energy source.

14. The method according to claim 13 , wherein said contacting step comprises contacting said electrode microneedle plate to an inner surface of a mouth of said mammal.

15. The method according to claim 13 , wherein said applying step comprises applying an electroporation-causing electrical pulse having characteristics of between 1V and 30V, 2 mA and 100 mA, or 1 mS and 250 mS.

Assignees

• Kemmerrer Stephen V
• Broderick Kate
• Mccoy Jay
• Inovio Pharmaceuticals Inc

Inventors

• Kemmerrer Stephen V
• Broderick Kate
• Mccoy Jay

Classifications

• Y02A50/30

  Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title

• C12M35/02

  Electrical or electromagnetic means, e.g. for electroporation or for cell fusion · CPC title

• A61N1/0424 Primary

  Shape of the electrode · CPC title

• C12N13/00

  Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title

• A61N1/0548

  Oral electrodes · CPC title